Page 113 - Clinical Immunology_ Principles and Practice ( PDFDrive )
P. 113

CHaPter 6  Overview of T-Cell Recognition                97



                   Activated APC
                                                                                                             Exclude long
                                                                                                             peptide
                                         Co-stimulation
                             APC-1
                                                                                                        MHC Class I
                                                                  β 2-microglobulin
                                                       Tcell
                                         MHC: peptide
                                          TCR match



                   Activated APC
                                                                                                        MHC Class II
                                                                  β-chain
                             APC-2

                                                       Tcell      FIG 6.6  Peptide Binding by Major Histocompatibility Complex
                                                                  (MHC) Class I and II Molecules. MHC class I molecules (top)
                                         MHC: peptide             are typically “closed” at both ends. Peptides that are too long
                                         TCR mismatch             must be cleaved prior to entry into the binding site. The clefts
           FIG 6.5  Major Histocompatibility Complex (MHC) Restriction   of class II molecules (bottom) are “open” at the ends, and thus
           Carries Out a Critical Function. Naive T cells (purple) respond   permit  the  binding  of  long  peptides.  Both  molecules  interact
           to cognate epitopes only when presented in association with   with peptides through both hydrogen bonding residues that are
           an MHC molecule on the surface of an antigen-presenting cell   directed by nonpolymorphic residues in the MHC molecule and
           (APC). APCs can be activated by antigen uptake, cytokines, or   that are thus conserved among different complexes, and anchor-
           pathogen-derived molecules, and this makes them more effective   pocket interactions that typically employ polymorphic residues
           at activation T cells. Experimentally observed MHC restriction   in the MHC molecule and thus vary for different MHC alleles
           reflects the need for the APC to bear the correct MHC that   and different peptides.
           matches the T cell (top). In the absence of a matched MHC,
           the T cell will be unable to respond to the peptide (bottom).
                                                                      KeY ConCePtS
                                                                   Antigen Uptake for Presentation to CD4 T Cells
           repertoire of presented peptides is widely available throughout   •  B cells acquire antigen through uptake by the immunoglobulin
           the body for scanning by circulating CD8 T cells.         receptor.
                                                                   •  C-type lectins expressed on the surface of many types of antigen-
           Class II MHC                                              presenting cell (APC) receptors promote the binding and internalization
                                                                     of antigen by the APCs.
           MHC class II proteins consist of a heterodimer of MHC-encoded,   •  Vaccines can be targeted to dendritic cells for CD4 T-cell priming by
           genetically polymorphic  α and  β chains. Peptide binding is   conjugation to C-type lectins and thus enhance antibody responses.
           controlled by a series of 4–5 pockets into which the amino acid
           side chain of peptides selectively dock. Allele-dependent amino
           acid diversity within these pockets permits varied binding of
           peptide fragments across individuals. Coupled with a network   MHC Class II Antigen Presentation
           of hydrogen-bonding residues between the main chain of the   MHC class II–restricted presentation of antigen to CD4 T cells
           peptide and the α helices of the MHC class II α and β chains   is sensitive to inhibitors of endosomal  proteolysis. Inhibitors
           that stretches along the entire binding cleft, the interaction   include pharmacological reagents that neutralize endosomes,
           between peptide and MHC class II can be exceptionally stable.   such as chloroquine or ammonium chloride, or specific protease
           The class II binding cleft is open and thus can bind peptides   inhibitors, such as leupeptin. These data have helped establish
           ranging in length from 13 to 20 amino acids (see Fig. 6.6, Bottom).  the  paradigm that  MHC class II  molecules  acquire  peptides
             Class II molecules are expressed on a restricted, but diverse,   generated by endosomal proteolysis of internalized protein
           set of cells that includes B cells, macrophages, monocytes, DCs,   antigens. This process involves a  number  of  cofactors  and
           and, in humans, activated T cells. Class II–bearing cells can activate   checkpoints that serve to regulate MHC class II molecule traf-
           CD4 T cells. CD4 Th cells promote expansion of B cells and   ficking to endosomal/lysosomal compartments, acquisition of
           their production of isotype-switched high-affinity antibodies.   peptide, and trafficking to the cell surface. These pathways and
           Interleukin-2 (IL-2)–secreting CD4 T cells facilitate CD8 T-cell   mediators control the ability of class II molecules  and their
           expansion and generation of long-lived CD8 T memory. CD4   peptides to be recognized by CD4 T cells. Central features include
           T cells can mediate protective immunity through secretion of   the mechanisms that direct sorting and localization of class II
           cytokines, such as interferon-γ (IFN-γ), which leads to killing   molecules to the intracellular endosomal compartment(s)
           of intracellular pathogens. Finally, CD4 T cells can directly kill   containing antigen, proteolytic enzymes that efficiently degrade
           infected host cells or class II–positive tumors via perforin- or   antigen into peptides, and cofactors that promote rapid binding
           granzyme-mediated cytotoxicity.                        of the appropriate peptides 16-19  (Fig. 6.7).
   108   109   110   111   112   113   114   115   116   117   118